Cyclists
Debate between Lord Taverne and Lord Ahmad of Wimbledon(9 years ago)
Lords ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Ahmad of Wimbledon
My noble friend raises a very important point about statistics. I will write to him on the first two issues. I think we acknowledge that the number of cyclists injured on the roads is increasing, but when we compare 2008 to 2014, the number of deaths on the road has not significantly increased. For example, 104 cyclist deaths were reported in 2008 and 113 in 2014, which is an increase of four on 2013 figures. Nevertheless, it is 113 deaths too many and we need to eradicate this problem.
Lord Taverne
My Lords, I hope the Minister will provide the figures that he says he will provide and make them available in the Library, although the serious injuries caused by cyclists must pale into insignificance when compared to those caused by motorists. Does he not agree that everything possible must be done by the Government to encourage and support cycling, as was splendidly shown recently with the opening of the cycling superhighway route in London? After all, bicycles are the most efficient machine yet invented for turning energy into motion. Indeed, the bicycle has been accurately described as a kind of green car, which can run on tap water and tea cakes and, moreover, has a built-in gym.
Lord Ahmad of Wimbledon
The noble Lord raises the benefits of cycling, about which I agree with him. I am sure he recognises that the Government have committed more than £100 million between now and 2021 in improving investment in both walking, for example through walking paths, and cycling. I have already alluded to the schemes that the Government are supporting, such as Bikeability.
Scientific Research and Development
Debate between Lord Taverne and Lord Ahmad of Wimbledon
Lord Ahmad of Wimbledon (Con)
My Lords, the Government recognise that investment in science and research are key to long-term competitiveness and growth. Therefore, we have protected the ring-fenced science and research programme at £4.6 billion per year from 2011-12 to 2015-16. Furthermore, we have committed to providing £1.1 billion a year of science capital spending, increasing with inflation.
Lord Ahmad of Wimbledon
As the noble Lord may be aware, the Government have a series of thematic priorities covering a range of things from agriculture and food to the built environment, the digital economy, energy, and health and care. Healthcare providers are also included in this, and these thematic priorities will formulate part of the strategy for 2014, to which I have alluded.
Lord Taverne
I apologise for my premature intervention. Are the Government aware—I am sure they are—that vice-chancellors are deeply concerned about the possibility of our exit from the European Union? This would have a devastating effect on scientific research and development in our universities.
Lord Ahmad of Wimbledon
The Government’s position is quite clear. The European Union has benefits and the Government wish to see a renegotiated Union—something that I think many noble Lords share. The Prime Minister has stood up for British interests. Universities are working closely with business and others, and the UK continues to be among the top in terms of research. Looking at some of the statistics, the UK has, for example, won 85 Nobel prizes for science and technology, and we plan that that should continue with the new strategy.
Drugs Policy
Debate between Lord Taverne and Lord Ahmad of Wimbledon
Lord Ahmad of Wimbledon
First, I pay tribute to the work the noble Baroness has done in this field. She has brought to the fore on many occasions the importance of reviewing drugs policy. The Government have taken a broad view of this. If we look at the statistics, it is commendable that drug usage domestically is down and we have seen a greater emphasis being put on helping people overcome drugs issues. Nevertheless, she may well be aware that there is an international comparators report due within the next two to three months, and we will be reviewing what we find in terms of best practice across a range of countries, not just within the EU.
Lord Taverne (LD)
My Lords, will the Government support the modernisation of schedule 1 through an evidence-based review process so that the great advances in medical science in the UK and elsewhere can be reflected in the wider availability of drugs for medical use?
Lord Ahmad of Wimbledon
I have already said that we are constantly reviewing our drugs policy to ensure that what we do is based on prevention and cure but also on enforcement. Evidence has shown that our current balanced approach is paying dividends and we need to ensure that we do not have a knee-jerk reaction to what is being proposed. I have already mentioned the comparators report, and other reviews internally will ensure that we continue to have a balanced view of this particularly sensitive area.